A multicenter Spanish study of atropine 0.01% in childhood myopia progression
Abstract To evaluate the efficacy and safety of atropine 0.01% eye drops for myopia control in a multicentric pediatric Spanish cohort. An interventional, prospective, multicenter study was designed. Children aged between 6 and 14 years, with myopia between − 2.00 D to − 6.00 D, astigmatism < 1.5...
Guardado en:
Autores principales: | Inés Pérez-Flores, Beatríz Macías-Murelaga, Jesús Barrio-Barrio, Multicenter Group of Atropine Treatment for Myopia Control (GTAM) |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/32fe47381c1f4625a9f94472eca1c0f8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy of combined orthokeratology and 0.01% atropine for myopia control: the study protocol for a randomized, controlled, double-blind, and multicenter trial
por: Ying Yuan, et al.
Publicado: (2021) -
Use baseline axial length measurements in myopic patients to predict the control of myopia with and without atropine 0.01.
por: Loreto V T Rose, et al.
Publicado: (2021) -
Safety and efficacy of 0.02% and 0.01% atropine on controlling myopia progression: a 2-year clinical trial
por: Can Cui, et al.
Publicado: (2021) -
Nitric Oxide (NO) Mediates the Inhibition of Form-Deprivation Myopia by Atropine in Chicks
por: Brittany J. Carr, et al.
Publicado: (2016) -
Risk factors for rapid axial length elongation with low concentration atropine for myopia control
por: Aicun Fu, et al.
Publicado: (2021)